Merck, Eisai to shut down late stage trial of liver cancer therapy Ruchika Sharma31 Oct 2025 1:41 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Eisai have announced that they will shut down the late-stage trial...
USFDA nod to updated indication for Winrevair in adults with Pulmonary Arterial Hypertension Ruchika Sharma28 Oct 2025 4:32 PM ISTRahway: Merck, known as MSD outside the United States and Canada, has announced that the company has received approval from the U.S. Food and...
Merck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev for bladder cancer Ruchika Sharma25 Oct 2025 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has...
Merck concludes USD 10 billion acquisition of Verona Pharma Ruchika Sharma8 Oct 2025 11:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the completion of the Verona Pharma plc acquisition....
Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants Ruchika Sharma21 Sept 2025 4:15 PM ISTRahway: Merck, known as MSD outside of the United States and Canada,,has announced that the Committee for Medicinal Products for Human Use (CHMP) of...
Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval Ruchika Sharma20 Sept 2025 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer Ruchika Sharma17 Sept 2025 1:03 PM ISTRahway: Merck, Daiichi Sankyo have announced that Raludotatug deruxtecan (R-DXd) has received Breakthrough Therapy Designation (BTD) from the U.S....
Merck's SpringWorks Therapeutics gets nod for Ogsiveo from European Commission for adults with Desmoid Tumors Ruchika Sharma22 Aug 2025 11:30 AM ISTStamford: SpringWorks Therapeutics, Inc., a healthcare company of Merck, has received marketing authorization from the European...
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer Ruchika Sharma19 Aug 2025 12:30 PM ISTRahway: Merck and Daiichi Sankyo have announced that Ifinatamab deruxtecan (I-DXd) has been granted Breakthrough Therapy Designation (BTD) by the...
Merck to begin Phase 3 trials for investigational once monthly HIV prevention pill Ruchika Sharma15 July 2025 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of the EXPrESSIVE Phase 3 clinical trials,...
Merck application for two drug regimen for adults with virologically suppressed HIV 1 infection under USFDA review Ruchika Sharma11 July 2025 12:19 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has...
Merck to buy Verona Pharma for USD 10 billion Ruchika Sharma10 July 2025 10:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Verona Pharma plc, a biopharmaceutical company focused on...
